Records containing: Leiomyosarcoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-07-23A Phase 1 Study of NM32-2668 (Anti-ROR1/CD3/Anti-HSA Tri-Specific Antibody) in Adult Patients With Selected Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-06-13A Phase 2/3 Study to Evaluate the Efficacy and Safety of Unesbulin in Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma
-
CLINICAL_TRIALS study record update · 2025-06-13Beliefs, Attitudes, and Response to Genetic Testing in Sarcoma Patients
-
CLINICAL_TRIALS study record update · 2025-06-03Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2
-
CLINICAL_TRIALS study record update · 2025-05-29A Phase 1 Study of Metronomic Selinexor in Select Soft Tissue Sarcomas and Split Dosing of Selinexor in All Soft Tissue Sarcomas
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-29Coordination of Rare Diseases at Sanford
-
CLINICAL_TRIALS study record update · 2025-02-24TAGGED: A Phase 2 Study Using Low Dose/Metronomic Trabectedin, Gemcitabine, and Dacarbazine as 2nd/3rd/4th Line Therapy for Advanced Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2024-12-27Phase II Trial of Single-Agent Nivolumab in Patients With Microsatellite Unstable/Mismatch Repair Deficient/Hypermutated Uterine Cancer
-
CLINICAL_TRIALS study record update · 2024-12-19ADMINISTRATION of LMP-SPECIFIC CYTOTOXIC T-LYMPHOCYTES to PATIENTS with RELAPSED EBV-POSITIVE LYMPHOMA
-
CLINICAL_TRIALS study record update · 2024-12-11A Phase I/II Study of TTI-621 in Combination With Doxorubicin in Patients With Unresectable or Metastatic High-Grade Leiomyosarcoma
-
CLINICAL_TRIALS study record update · 2024-11-25A Single-arm Phase Ib/II Study of the Combination of Lenvatinib and Eribulin in Advanced Adipocytic Sarcoma and Leiomyosarcoma (LEADER Study)
-
CLINICAL_TRIALS study record update · 2024-07-30A Phase III Randomized Controlled Trial of Chest CT vs Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2024-07-25The Role of Pre-Surgical Tru - Cut Biopsy in the Management of Atypical Myometrial Lesions
-
CLINICAL_TRIALS study record update · 2024-03-15A Phase 1B Study of Unesbulin (PTC596) in Combination With Dacarbazine in Patients With Locally Recurrent, Unresectable or Metastatic Relapsed/Refractory Leiomyosarcoma
-
CLINICAL_TRIALS study record update · 2023-12-26Concordance Between Gynaecologic Sonography Amd Pelvic MRI for the Pre-surgical Diagnosis of Uterine Mesenchymal Malignant Tumors
-
CLINICAL_TRIALS study record update · 2023-12-06A Phase II Study, With a Safety lead-in, to Evaluate ATX-101, a Peptide Drug Targeting PCNA, in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma
-
CLINICAL_TRIALS study record update · 2023-11-07A Non-Inferiority Study of Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2023-11-02A Phase 1-2 Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents in Subjects With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2023-10-10A Randomized Study Comparing the Efficacy of the Combination of Doxorubicin and the Tumor-targeting Human Antibody-cytokine Fusion Protein L19TNF to Doxorubicin Alone as First-line Therapy in Patients With Metastatic Leiomyosarcoma
-
CLINICAL_TRIALS study record update · 2023-07-07A Phase II Study of M6620 (VX-970) in Selected Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-05-31Phase I-II Prospective Trial, Multicenter, Open Label, Exploring the Combination of Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
-
CLINICAL_TRIALS study record update · 2023-03-06An In Depth Study Investigating The Experiences of Patients In Leiomyosarcoma Clinical Trials
-
CLINICAL_TRIALS study record update · 2022-08-31A Pilot Study of Patient Reported Outcomes When Treated With Trabectedin for Unresectable and/or Metastatic Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2022-01-24A Phase II Study of Temozolomide for Injection Combined With Epirubicin in the First-line Treatment of Leiomyosarcoma
-
CLINICAL_TRIALS study record update · 2021-12-07A Phase 2 Study of 9-ING-41, a Glycogen Synthase Kinase-3 Beta (GSK-3β) Inhibitor, Combined With Chemotherapy in Advanced Soft Tissue and Bone Sarcomas